Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Peters

Showing results (1111-1120 of 1,183) with videos related to

Pageof 119
Sort By:
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acidB Combes, R L Carithers, W C Maddrey, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Design and synthesis of potent, non-peptidic inhibitors of HPTPbetaKande K D Amarasinghe, Artem G Evdokimov, Artem G Evidokimov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2025
"Bone biopsy not superior to ulcer bed biopsy guided antibacterial therapy on remission of diabetic foot osteomyelitis: A randomized controlled trial"Rimke S Lagrand, Louise W E Sabelis, Meryl C T T Gramberg, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Diabetes/Metabolism Research and Reviews|May 15, 2023
Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update)Jaap J van Netten, Sicco A Bus, Jan Apelqvist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug ClassesMarion G Peters, Man-Fung Yuen, Norah Terrault, et al.
Pageof 119

Showing results (1111-1120 of 1,183) with videos related to

Sort By:
Pageof 119
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acidB Combes, R L Carithers, W C Maddrey, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Design and synthesis of potent, non-peptidic inhibitors of HPTPbetaKande K D Amarasinghe, Artem G Evdokimov, Artem G Evidokimov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2025
"Bone biopsy not superior to ulcer bed biopsy guided antibacterial therapy on remission of diabetic foot osteomyelitis: A randomized controlled trial"Rimke S Lagrand, Louise W E Sabelis, Meryl C T T Gramberg, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Diabetes/Metabolism Research and Reviews|May 15, 2023
Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update)Jaap J van Netten, Sicco A Bus, Jan Apelqvist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug ClassesMarion G Peters, Man-Fung Yuen, Norah Terrault, et al.
Pageof 119